Literature DB >> 3917732

Cardiac arrest after treatment with intravenous domperidone.

H A Cameron, A J Reyntjens, G Lake-Bakaar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3917732      PMCID： PMC1415492          DOI： 10.1136/bmj.290.6462.160-c

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Sudden death in cancer patient on high-dose domperidone.

Authors:  R A Joss; A Goldhirsch; K W Brunner; R L Galeazzi
Journal:  Lancet       Date:  1982-05-01       Impact factor: 79.321

2.  Cardiac arrest after treatment with intravenous domperidone.

Authors:  J B Roussak; P Carey; H Parry
Journal:  Br Med J (Clin Res Ed)       Date:  1984-12-08

3.  Magnesium in cardiology.

Authors:  T Dyckner; P O Wester
Journal:  Acta Med Scand Suppl       Date:  1982

Review 4.  Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic.

Authors:  R N Brogden; A A Carmine; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-11       Impact factor: 9.546
  4 in total
  8 in total

Review 1.  Domperidone, a new dopamine antagonist.

Authors:  M C Champion; M Hartnett; M Yen
Journal:  CMAJ       Date:  1986-09-01       Impact factor: 8.262

2.  Characterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitro.

Authors:  Bryan A Ward; Alan Morocho; Abdullah Kandil; Raymond E Galinsky; David A Flockhart; Zeruesenay Desta
Journal:  Br J Clin Pharmacol       Date:  2004-09       Impact factor: 4.335

3.  Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysis.

Authors:  Frederique Fenneteau; Jun Li; Fahima Nekka
Journal:  J Pharmacokinet Pharmacodyn       Date:  2009-10-22       Impact factor: 2.745

4.  An open study to assess the safety, tolerance and pharmacokinetics of an intravenous infusion of granisetron given at 3 mg over 30 s in patients receiving chemotherapy for malignant disease.

Authors:  J Carmichael; P A Philip; C Forfar; A L Harris
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

5.  Pharmacokinetic interaction between domperidone and ketoconazole leads to QT prolongation in healthy volunteers: a randomized, placebo-controlled, double-blind, crossover study.

Authors:  Malcolm J Boyce; Kathy J Baisley; Steven J Warrington
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

6.  Saudi Gastroenterology Association position statement on safety issues associated with the use of domperidone.

Authors:  Mahmoud H Mosli; Bandar Aljudaibi; Majid Al-Madi
Journal:  Saudi J Gastroenterol       Date:  2014 Sep-Oct       Impact factor: 2.485

7.  Effect of domperidone on the QTc interval in premature infants.

Authors:  A Günlemez; A Babaoğlu; A E Arisoy; G Türker; A S Gökalp
Journal:  J Perinatol       Date:  2009-07-23       Impact factor: 2.521

8.  Assessing drug distribution in tissues expressing P-glycoprotein through physiologically based pharmacokinetic modeling: model structure and parameters determination.

Authors:  Frédérique Fenneteau; Jacques Turgeon; Lucie Couture; Véronique Michaud; Jun Li; Fahima Nekka
Journal:  Theor Biol Med Model       Date:  2009-01-15       Impact factor: 2.432
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.